Vandria

Series-A
vandria.com Biotech & Healthcare Epalinges, Switzerland 1–10 employees
Total Funding $51.3M
Latest Round $30.7M Series-A
Last Announced Aug 21, 2024
Investors 5 Backers
Decision Makers 5 Available

About Vandria

We are developing first-in-class small molecules against a novel target to improve mitochondrial function and reduce chronic inflammation to treat age-related diseases.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Epalinges, Switzerland
Team Size 1–10 employees
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website vandria.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $30,700,000 · Series-A

    Backed by +ND Capital

  2. Capital Raise

    Raised $20,600,000 · Series-A

    Backed by +ND Capital

Investors & Backers

5
+ND Capital
Lead
Dolby Family Ventures
Eurostars
Hevolution Foundation
Innosuisse

Funding History

2 Rounds
Series-A equity · Aug 21, 2024

Round backers: +ND Capital

Series-A equity · Dec 14, 2023

Round backers: +ND Capital

$20,600,000 startupticker.ch

Founders & Leadership

1

Peter Harboe-Schmidt

Head of Finance

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts